CoImmune   Report issue

For profit Phase 2
Founded: Durham NC United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04203901
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CoImmune